Home › Postural Orthostatic Tachycardia Syndrome › NCT07197905
Restoring Iron Deficiency in POTS
Restoring Iron Deficiency to Expand Blood Volume and Improve POTS
Who can join
Ages 18 to 45 · Women
Full eligibility criteria
Inclusion Criteria * Age 18-45 years old. * Diagnosis of POTS, defined by a sustained heart rate increase of at least 30 bpm within 10 min of standing or head-up tilt (or absolute upright heart rate \>120 bpm), in the absence of orthostatic hypotension, and with at least 3 months of symptoms of orthostatic intolerance. * Absence of other diseases or medications that can explain orthostatic tachycardia or symptoms. * Serum ferritin \<50 ng/ml. * Patients on fludrocortisone will be allowed to participate as long as they have been on the same dose for at least one month before enrollment and continue on the same dose throughout the study. Exclusion Criteria * Unable or unwilling to provide consent. * Pregnancy. * Being chair- or bed-ridden. * Unable to hold POTS medications during study procedures (i.e., autonomic testing). * History of active bleeding (other than menstruation). * History of hypersensitivity to any iron preparation of recent (within 6 months) treatment with any IV iron preparation.
About the study
People with postural orthostatic tachycardia syndrome (POTS) often have low red blood cell volumes and low ferritin in their blood (a marker of iron storage in the body). The purpose of this pilot study is to investigate whether giving iron to people with POTS who have low ferritin levels will increase the red blood cell volume and improve POTS symptoms.
What is being tested
- Intravenous iron (drug)
Sponsor: Vanderbilt University Medical Center · Participants: 12 · Started: Nov 24, 2025
Contact the study team
- Megan Orillion, BSN, RN · Phone: 615-875-9405
- Luis E Okamoto, MD · Phone: 615-936-6119
Official record on ClinicalTrials.gov — NCT07197905
Locations in the U.S.
| Tennessee | Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.